Healthcare Industry News

Nurse Call Systems Market Worth $4.0 billion by 2029 ✅𝐆𝐞𝐭 𝐔𝐥𝐭𝐢𝐦𝐚𝐭𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞-https://lnkd.in/dGVafamz The global nurse call systems market in terms of revenue was estimated to be worth $2.5 billion in 2024 and is poised to reach $4.0 billion by 2029, growing at a CAGR of 10.2% from 2024 to 2029 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Ametek, Inc. (US), Baxter International, Inc. (US), ASCOM Holdings AG (Switzerland), Johnson Controls (US), Securitas Healthcare (US) 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 West-Com Nurse Call Systems, Inc.  Systems Technologies Nurse Call Systems      Yarward Nurse Call Systems -Medical equipment      Vocera Communications, now part of Stryker     Jeron Electronic Systems, Inc./Provider®Nurse Call      Curbell, Inc. Curbell Medical Marlowe Fire & Security Smart Directions Company    Galaxy Integrated Technologies, Inc.      PROMEDIC Holding Miller Electric Company of Omaha      HatchMed Narula Udyog Group INA Alert, Inc.      Tediselmedical Cornell Communications, Inc. Inma Synergy Medical Systems Ltd   Applied Engineering Services   MHD Tektraco      Fulton Communications Jawad Sultan Technologies Resonent TechnoLabs Pvt. Ltd.   MDC Low Voltage Systems Fire Safe Protection Services, LP   Teltrac Mac Systems, Inc.   Shea Electric & Communications LLC

Biopreservation Market Worth $7.1 billion by 2029 ✅𝐆𝐞𝐭 𝐔𝐥𝐭𝐢𝐦𝐚𝐭𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞-https://lnkd.in/eaif7ea9 The size of global biopreservation market in terms of revenue was estimated to be worth $4.4 billion in 2024 and is poised to reach $7.1 billion by 2029, growing at a CAGR of 9.8% from 2024 to 2029 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), PHC Holdings Corporation (Japan), Azenta, Inc. (US), Sartorius AG (Germany), Avantor, Inc. (US), ThermoGenesis Holdings, Inc. (US), Bio-Techne Corporation (US), BioLife Solutions Inc. (US), and Cryoport Inc. (US). 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 CooperSurgical Fertility Solutions    Brooks Life Sciences      X-Therma Inc.    nexAir, LLC   Greiner Bio-One Americas  Nkarta, Inc.  OrganaBio AllCells STEMCELL Technologies Ossium Health Cellular Technology Limited — CTL OriGen Biomedical  Bioscience Institute    IMV Technologies  Greiner Bio-One International   Pluristyx, Inc. Gaylord Chemical Company, LLC     Taylor-Wharton America      ORIGIO Future Fertility    Faculty of Engineering, University of Alberta Cordlife Indonesia (PT Cordlife Persada)  BioRep Embryolab Fertility Clinic      Seeds of Innocens IVF & Fertility Centres      Biopharma Group Minitube International     Bourn Hall Fertility Clinic UAE  CellBios Alcor Life Extension Foundation      Cordlife India    Evia Bio     Cryo-Cell Nova IVF Fertility Cradle Cordlife Singapore Cryo-Save Group BebéVida SciSafe Inc.

Microcarriers Market Worth $3.3 billion by 2028 ✅𝐆𝐞𝐭 𝐔𝐥𝐭𝐢𝐦𝐚𝐭𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞-https://lnkd.in/dn8Bnm39 The global microcarriers market in terms of revenue was estimated to be worth $2.0 billion in 2023 and is poised to reach $3.3 billion by 2028, growing at a CAGR of 10.0% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), Danaher Corporation, (US), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US), Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), ChemoMetec (Denmark), Esco Lifesciences Group Ltd (Singapore), etc. 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Cell Culture Company Cell Microsystems Cell X Technologies   Key Corporate Services, LLC Hamilton Company Bruker Nano Surfaces & Metrology Nova Biomedical    Emulate, Inc. FUJIFILM Irvine Scientific Nucleus Biologics GALY Advanced BioMatrix InvivoGen PBS Biotech TheWell Bioscience  Visikol ScienCell Research Laboratories      GBI Bio ScaleReady Chanshow Biotechnology Inc GeminiBio STEMCELL Technologies Kemwell Biopharma Trailhead Biosystems Premas Biotech    Laurus Bio Novo Nordisk Pharmatech A/S     Imperial Life Sciences Pvt Ltd. Azbil Telstar Systems Ally  NOVÉAL-L'Oréal Groupe Instituto de Agroquímica y Tecnología de Alimentos IATA CSIC      VIRCELL S.L. IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. BioLamina GenIbet Biopharmaceuticals ARTeSYN, A Repligen Company Ronawk Nanomedicine Research Group, ICTMumbai  ProBioGen AG

Intraocular Lens Market Worth $6.0 billion by 2029 ✅𝐆𝐞𝐭 𝐔𝐥𝐭𝐢𝐦𝐚𝐭𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞-https://lnkd.in/dwSZBWZf The intraocular lens market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $6.0 billion by 2029, growing at a CAGR of 6.3% from 2023 to 2029 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Alcon Inc. (US), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec AG (Germany), Hoya Corporation (Japan), Bausch & Lomb (US), STAAR Surgical (US), Santen Pharmaceutical Co., Ltd. (Japan), NIDEK Co., Ltd. (Japan), LENSTEC, Inc. (US), Rayner Group (England), etc. 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Hoya Vision Care LENS CRAFT OPTICS   Optimum RX Lens Specialists Hoya Lens Italia Hoya Lens Poland Opak Lens Hoya Lens Deutschland GmbH    Omni Lens Pvt Ltd  Hoya Lens Switzerland AG Precision Lens Austral Lens Colombia S.A.S Hoya Lens Belgium nv American Lens Poland Art Optical Contact Lens, Inc.   RxSight, Inc.   ABB OPTICAL GROUP   Visionix USA (formerly Luneau Technology USA & Optovue Inc.)      LENSAR, Inc.    Shifamed      Hoya Vision Care CooperVision Specialty Americas      The Fred Hollows Intraocular lens Laboratory (FH IOL Lab), Tilganga Eye Centre Shamir Insight   Aurolab     Shamir Optical Industry Itd.      STAAR Surgical      Santinelli International VISION EASE Appasamy Associates Euclid Vision Corporation      CIBA Vision AccuLab of Illinois    Uni-Lens Industria E Comercio Atacadista E Varejista De Lentes      Presbia Walman Optical Younger Optics Advanced Vision Science Inc. (A Santen Company)      Medicontur   Hanita Lenses Ltd.

Stem Cell Manufacturing Market Worth $21.8 billion by 2028 ✅𝐆𝐞𝐭 𝐔𝐥𝐭𝐢𝐦𝐚𝐭𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞-https://lnkd.in/e2vDGMXa The global stem cell manufacturing market in terms of revenue was estimated to be worth $12.7 billion in 2023 and is poised to reach $21.8 billion by 2028, growing at a CAGR of 11.3% from 2023 to 2028 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza Group (Switzerland), Danaher Corporation (US), Sartorius AG (Germany), Becton, Dickinson, and Company (US), Eppendorf AG (Germany), Corning Inc. (US), Bio-Rad Laboratories (US), Takara Bio Group (Japan), Fujifilm Holdings Corporation (Japan), Getinge AB (Sweden), Terumo Corporation (Japan), Bio-Techne Corporation (US), HiMedia Laboratories (India), StemCell Technologies, Inc. (Canada), Miltenyi Biotec GmBH (Germany), PromoCell (Germany), Anterogen Co. Ltd. (South Korea), CellGenix GmBH (India), Pluristem Therapeutics Inc. (Israel), Daiichi Sankyo (Japan), Organogenesis Holdings Inc. (US), Vericel Corporation (US), and American Cryostem Corporation (US). 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Stem Cell Network The Stem Cell Institute Stem Cell Medicine Stem Cell Sciences Stem Cell and Cancer Institute Stem Cell Research Center (STRC) Stem Cell Club Harvard Stem Cell Institute Institute for Stem Cell Science and Regenerative Medicine (DBT-inStem)   International Stem Cell Corporation Lund Stem Cell Center International Society for Stem Cell Research The New York Stem Cell Foundation Research Institute     Centre for Stem Cell and Cancer Genomics, AM Institute of BioScience  U.S. Stem Cell, Inc USC Stem Cell Cambridge Stem Cell Institute Hortman Stem Cell Laboratory Royan Stem Cell Technology Co. UCLA Broad Stem Cell Research Center DATRI Blood Stem Cell Donors Registry Hubrecht Institute, Developmental Biology and Stem Cell Research Novo Nordisk Foundation Center for Stem Cell Medicine – reNEW   Plexus Neuro and Stem cell research centre McEwen Stem Cell Institute Stanford Institute for Stem Cell Biology and Regenerative Medicine AKU Centre for Regenerative Medicine and Stem Cell Research R3 Stem Cell Auragens - Stem Cell Center Centre for Stem Cell Research ,Department of Biotechnology,Christian Medical College UW Institute for Stem Cell and Regenerative Medicine  Regenerative Research Foundation/Neural Stem Cell Institute  Stem Genomics REVOOBIT STEM CELL PRODUCTS      Cell Safe Cord Blood Bank DKMS Stem Cell Bank Cell Care Australia HI-STEM gGmbH: The Heidelberg Institute for Stem Cell Technology and Experimental Medicine    ESTEM

Ultrasound Market Worth $11.6 billion by 2028 ✅𝐆𝐞𝐭 𝐔𝐥𝐭𝐢𝐦𝐚𝐭𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞-https://bit.ly/4dP6hbF The global ultrasound market in terms of revenue was estimated to be worth $8.5 billion in 2023 and is poised to reach $11.6 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Fujifilm Corporation (Japan), and Hologic, Inc. (US) 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Ultrasound Solutions Corp Sonoscanner - Premium Ultrasound Scanners      CHISON Ultrasound Manufacturer Advanced Ultrasound Systems      Intelligent Ultrasound National Ultrasound, Inc. Daxsonics Ultrasound Inc. Trisonics - Ultrasound Service & Sales VINNO Ultrasound Butterfly Network, Inc. Verathon FUJIFILM Sonosite, Inc. Canon Medical Systems USA, Inc. BK Medical Mindray North America  Natus Medical Incorporated Konica Minolta Healthcare Americas, Inc. Toshiba America Medical Systems Samsung NeuroLogica  Mammotome EchoNous NeuraSignal Delta Medical Systems Sofwave iota Biosciences, Inc. powered by Astellas FUJIFILM Healthcare Americas Corporation Misonix MXR Imaging, Inc. CIVCO Medical Solutions

Digital Therapeutics Market Worth $21.9 billion by 2028 ✅𝐆𝐞𝐭 𝐔𝐥𝐭𝐢𝐦𝐚𝐭𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞-https://bit.ly/3zhdBxs The digital therapeutics market is projected to reach USD 21.9 billion by 2028 from USD 6.1 billion in 2023, at a CAGR of 29.1% during the forecast period. ✅Software/Platforms segment is anticipated to garner the highest share during the forecast period. ✅Business-to-Buisness segment is anticipated to account for the lion’s share of digital therapeutics market, by Sales in 2022. ✅Care-related/Treatment applications are the highest share of the digital therapeutics market, by applications in 2022. ✅North America to lead the digital therapeutics market in 2022. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc (US), Biofourmis (US), Better Therapeutics, Inc (US), Amalgm Rx (US), CogniFit Inc (US), Headspace Health (US), Propeller Health (US), Virta Health Corp (US), 2Morrow, Inc. (US), Realizedcare (US), Canary Health (US), Twill Inc. (US), Click Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt. Ltd. (India), Kaia Health (Germany), Ayogo (Canada), Mindable Health GmbH (Germany), Hinge Health, Inc. (US), and Freespira (US). 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Digital Therapeutics Alliance      Centre for Digital Therapeutics        Curio Digital Therapeutics Inc.   Click Therapeutics, Inc.    Better Therapeutics      Virgin Pulse Kaia Health DarioHealth      Lupin Digital Health      Glooko Proxima CRO Xealth MedRhythms, Inc. RealizedCare SPRIM PRO Human API Care Innovations®      Blue Note Therapeutics  HTD Health Avegen MindMaze Fitterfly Resolute (HumanFractal.Ai) Rx.Health (Commure Engage) HelloBetter Alopa Infotech

Telehealth & Telemedicine Market Worth $285.7 billion by 2028 ✅𝐆𝐞𝐭 𝐔𝐥𝐭𝐢𝐦𝐚𝐭𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞-https://bit.ly/3ZchxKD The global telehealth & telemedicine market, projected to grow from $120.4 billion in 2023 to $285.7 billion by 2028 at a CAGR of 23.2% ✅Software and services segment accounted for a substantial share of the telehealth & telemedicine industry, by Component in 2022. ✅Providers segment accounted for a considerable share in the telehealth & telemedicine industry, by end user in 2022 ✅Web bases delivery mode accounted for the largest share in telehealth & telemedicine industry by Delivery mode in 2022 ✅North America dominated the telehealth & telemedicine industry in 2022 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 GE Healthcare (US), Oracle (US), Siemens Healthcare GmbH (Germany), Cisco Systems (US), Asahi Kasei Corporation (Japan), Iron Bow Technologies (US), American Well (US), AMC Health (US), TeleSpecialists (US), Doctor On Demand by Included Health, Inc. (US), MDLIVE (US), GlobalMedia Group, LLC (US), Medweb (US), VSee (US), Imedi Plus (China), ACL Digital (US), iCliniq (US). 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 INVIZA® Health — Powering Telehealth Connectivity™ ModMed Tebra KANINI Therapy Brands  Kareo, a Tebra company      SimplePractice Circadia Health Eko Health Certified Languages International Visionix USA (formerly Luneau Technology USA & Optovue Inc.) ABM Respiratory Care Glooko DoseSpot  binah.ai   TytoCare   Capsa Healthcare Hubino DexCare   Valant ZOLL Itamar THREAD MediView XR, Inc.    Howard Medical BioSensics Zyter|TruCare      Skyscape CometChat     Doctolib Connected Solutions Group, LLC 

Medical Aesthetics Market Worth $25.9 Billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬:https://lnkd.in/e2-GGCfY The global medical aesthetics market in terms of revenue was estimated to be worth $15.4 billion in 2023 and is poised to reach $25.9 billion by 2028, growing at a CAGR of 11.0% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 AbbVie Inc. (US), Alma Lasers (Israel), Cynosure (US), and Galderma ( Switzerland), among others. 𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Hugel Aesthetics SkinSpirit BTL Medical & Healthcare Technologies      Envy Medical, Inc. ZELTIQ RVL Pharmaceuticals      Allergan Data Labs      Aesthetic Management Partners   National Laser Institute EndyMed Medical Belo Medical Group, Inc. Advanced MedAesthetic Partners   Alpha Aesthetics Partners      HerMD The Skin Center Obagi Skin Health Institute      Hologic Costa Rica      Venus Aesthetic Intelligence      Hela Medical Spa Georgetown      BTL Industries Beyond Medical Group      Alma Lasers  BTL India Private Ltd BioScience GmbH   Arseus Medical Vanity Cosmetic Surgery Hospital      Clinique Chloé CollPlant  Biopark Medical    ELEVAI Labs Inc. 

Veterinary Ophthalmology Equipment Market Worth $697 Million by 2029 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬:https://lnkd.in/dk9vq5CD The size of global veterinary ophthalmology equipment market in terms of revenue was estimated to be worth $485 million in 2024 and is poised to reach $697 million by 2029, growing at a CAGR of 7.5% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Bausch + Lomb Revenio Group Oyj Halma plc Baxter International Inc. Alcon AMETEK HEINE Optotechnik LKC Technologies Iridex Optomed Plc OCULARVISION, INC. Vision-Box, an AMADEUS company Eidolon Optical, LLC OcuScience GerVetUSA Kowa American Corporation AJL OPHTHALMIC S.A OptiBrand Rx New World Medical FREEDOM OPHTHALMIC PVT LTD I-MED Animal Health CorNeat Vision